Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeting tyrosine kinases involved in cancer cell proliferation. Shows potential in the development of anticancer agents due to its ability to modulate signaling pathways in tumor cells. Also employed in structure-activity relationship (SAR) studies to optimize drug candidates for improved potency and selectivity. Its bromo-substituted pyrimidine framework allows for further functionalization via cross-coupling reactions, making it valuable in medicinal chemistry for generating diverse compound libraries.